chr6-154093311-A-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001008505.2(OPRM1):​c.1206A>T​(p.Gln402His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.773 in 1,612,926 control chromosomes in the GnomAD database, including 485,112 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).

Frequency

Genomes: 𝑓 0.82 ( 51993 hom., cov: 32)
Exomes 𝑓: 0.77 ( 433119 hom. )

Consequence

OPRM1
NM_001008505.2 missense

Scores

15

Clinical Significance

drug response no assertion criteria provided O:1

Conservation

PhyloP100: -0.683
Variant links:
Genes affected
OPRM1 (HGNC:8156): (opioid receptor mu 1) This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.5697856E-6).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.927 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPRM1NM_000914.5 linkc.1164+1839A>T intron_variant Intron 3 of 3 ENST00000330432.12 NP_000905.3 P35372-1G8XRH5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPRM1ENST00000330432.12 linkc.1164+1839A>T intron_variant Intron 3 of 3 1 NM_000914.5 ENSP00000328264.7 P35372-1

Frequencies

GnomAD3 genomes
AF:
0.822
AC:
124996
AN:
152066
Hom.:
51942
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.935
Gnomad AMI
AF:
0.728
Gnomad AMR
AF:
0.823
Gnomad ASJ
AF:
0.789
Gnomad EAS
AF:
0.940
Gnomad SAS
AF:
0.860
Gnomad FIN
AF:
0.804
Gnomad MID
AF:
0.775
Gnomad NFE
AF:
0.747
Gnomad OTH
AF:
0.833
GnomAD3 exomes
AF:
0.809
AC:
201769
AN:
249428
Hom.:
82340
AF XY:
0.805
AC XY:
108909
AN XY:
135314
show subpopulations
Gnomad AFR exome
AF:
0.937
Gnomad AMR exome
AF:
0.865
Gnomad ASJ exome
AF:
0.785
Gnomad EAS exome
AF:
0.933
Gnomad SAS exome
AF:
0.850
Gnomad FIN exome
AF:
0.803
Gnomad NFE exome
AF:
0.748
Gnomad OTH exome
AF:
0.794
GnomAD4 exome
AF:
0.768
AC:
1121764
AN:
1460744
Hom.:
433119
Cov.:
41
AF XY:
0.769
AC XY:
558870
AN XY:
726770
show subpopulations
Gnomad4 AFR exome
AF:
0.939
Gnomad4 AMR exome
AF:
0.862
Gnomad4 ASJ exome
AF:
0.785
Gnomad4 EAS exome
AF:
0.932
Gnomad4 SAS exome
AF:
0.846
Gnomad4 FIN exome
AF:
0.798
Gnomad4 NFE exome
AF:
0.745
Gnomad4 OTH exome
AF:
0.781
GnomAD4 genome
AF:
0.822
AC:
125103
AN:
152182
Hom.:
51993
Cov.:
32
AF XY:
0.826
AC XY:
61468
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.935
Gnomad4 AMR
AF:
0.822
Gnomad4 ASJ
AF:
0.789
Gnomad4 EAS
AF:
0.940
Gnomad4 SAS
AF:
0.858
Gnomad4 FIN
AF:
0.804
Gnomad4 NFE
AF:
0.747
Gnomad4 OTH
AF:
0.833
Alfa
AF:
0.755
Hom.:
29749
Bravo
AF:
0.830
TwinsUK
AF:
0.735
AC:
2724
ALSPAC
AF:
0.750
AC:
2891
ESP6500AA
AF:
0.938
AC:
3683
ESP6500EA
AF:
0.762
AC:
6342
ExAC
AF:
0.808
AC:
97627
Asia WGS
AF:
0.898
AC:
3123
AN:
3478
EpiCase
AF:
0.750
EpiControl
AF:
0.754

ClinVar

Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Tramadol response Other:1
Apr 28, 2018
Bruce Budowle Laboratory, University of North Texas Health Science Center
Significance: drug response
Review Status: no assertion criteria provided
Collection Method: research

- T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.51
DANN
Benign
0.095
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0029
N
LIST_S2
Benign
0.20
T
MetaRNN
Benign
0.0000016
T
MetaSVM
Benign
-0.98
T
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.13
N
REVEL
Benign
0.095
Sift
Benign
0.67
T
Sift4G
Benign
0.45
T
Polyphen
0.0
B
Vest4
0.021
ClinPred
0.000031
T
GERP RS
-4.6

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs540825; hg19: chr6-154414446; COSMIC: COSV57676965; COSMIC: COSV57676965; API